Estia Health Limited operates residential aged care homes in Australia. More Details
No risks detected for EHE from our risk checks.
Mediocre balance sheet with moderate growth potential.
Share Price & News
How has Estia Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EHE is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: EHE's weekly volatility (6%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: EHE exceeded the Australian Healthcare industry which returned 24.1% over the past year.
Return vs Market: EHE exceeded the Australian Market which returned 37.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Estia Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall StIntroducing Estia Health (ASX:EHE), A Stock That Climbed 74% In The Last Year
3 weeks ago | Simply Wall StEstia Health (ASX:EHE) Use Of Debt Could Be Considered Risky
1 month ago | Simply Wall StHow Many Estia Health Limited (ASX:EHE) Shares Did Insiders Buy, In The Last Year?
Is Estia Health undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: EHE (A$2.45) is trading above our estimate of fair value (A$1.03)
Significantly Below Fair Value: EHE is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: EHE is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average.
PE vs Market: EHE is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EHE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EHE is good value based on its PB Ratio (1.1x) compared to the AU Healthcare industry average (1.7x).
How is Estia Health forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: EHE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: EHE's is expected to become profitable in the next 3 years.
Revenue vs Market: EHE's revenue (3.2% per year) is forecast to grow slower than the Australian market (5.5% per year).
High Growth Revenue: EHE's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EHE's Return on Equity is forecast to be low in 3 years time (3.5%).
How has Estia Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EHE is currently unprofitable.
Growing Profit Margin: EHE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EHE is unprofitable, and losses have increased over the past 5 years at a rate of 48.5% per year.
Accelerating Growth: Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (25.5%).
Return on Equity
High ROE: EHE has a negative Return on Equity (-22.6%), as it is currently unprofitable.
How is Estia Health's financial position?
Financial Position Analysis
Short Term Liabilities: EHE's short term assets (A$68.7M) do not cover its short term liabilities (A$1.0B).
Long Term Liabilities: EHE's short term assets (A$68.7M) do not cover its long term liabilities (A$272.6M).
Debt to Equity History and Analysis
Debt Level: EHE's debt to equity ratio (17.4%) is considered satisfactory.
Reducing Debt: EHE's debt to equity ratio has reduced from 26.6% to 17.4% over the past 5 years.
Debt Coverage: EHE's debt is well covered by operating cash flow (74%).
Interest Coverage: EHE is unprofitable, therefore interest payments are not well covered by earnings.
What is Estia Health current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EHE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EHE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: EHE is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. He joined Estia Health in October 2016. Mr. Thorley was the Chief Operating Officer of Esti...
CEO Compensation Analysis
Compensation vs Market: Ian's total compensation ($USD582.81K) is about average for companies of similar size in the Australian market ($USD706.94K).
Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.
Experienced Management: EHE's management team is considered experienced (3.1 years average tenure).
Experienced Board: EHE's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Estia Health Limited's company bio, employee growth, exchange listings and data sources
- Name: Estia Health Limited
- Ticker: EHE
- Exchange: ASX
- Founded: 2005
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: AU$650.624m
- Shares outstanding: 261.29m
- Website: https://www.estiahealth.com.au
Number of Employees
- Estia Health Limited
- 227 Elizabeth Street
- Level 9
- New South Wales
Estia Health Limited operates residential aged care homes in Australia. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/06 08:21|
|End of Day Share Price||2021/05/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.